• Thurs news: Moderna targets $1.1B in R&D spending cuts. Gene therapy startup emerges. J&J leads $50M financing for imaging company. Sanofi gets into radioligands. GSK’s mRNA flu vax trial. See more on our front page

Is bigger better?

Anonymous

Guest
A really good case in point is Afrezza.

PFE tried it with Exubera (the BONG inhaler), the we tried something similar, then NOVO.... all failed.... but all it took was a team of open minded free thinkers in Valencia to engineer something that was not only effective but better than anything on the market.

We here at Lilly are so political and old boy-old girl network.... it is disgusting. You want real friends? Here you better find them .... somewhere else.........................